Veru Inc. Quarterly report [Sections 13 or 15(d)]

Note 4 - Fair Value Measurements (Details Textual) - USD ($)		3 Months Ended
	Sep. 22, 2025	Dec. 31, 2025	Dec. 31, 2024	Sep. 30, 2025
Proceeds from Sale of Equity Securities, FV-NI		$ 0	$ 393,217
Equity Securities, FV-NI, Unrealized Gain (Loss)		$ (120,078)	(349,078)
Series D Preferred Stock [Member] \| ONCO [Member]
Investment Owned, Balance, Shares (in shares)	16,099	3,125		3,125
ONCO Warrant [Member]
Investment Owned, Balance, Shares (in shares)	846,975
ONCO Warrant [Member] \| ONCO [Member]
Investment Owned, Balance, Shares (in shares)	4,362,827	846,975		846,975
ONCO Series D Preferred Stock and ONCO Warrant [Member] \| ONCO [Member]
Proceeds from Sale of Equity Securities, FV-NI	$ 12,900,000
Common Stock [Member]
Equity Securities, FV-NI, Unrealized Gain (Loss)			$ (300,000)
Common Stock [Member] \| ONCO [Member]
Investment Owned, Balance, Shares (in shares)			142,749
Proceeds from Sale of Equity Securities, FV-NI			$ 400,000